Andere Sprachen EDAP TMS S.A.

Aktien

908548

US2683111072

EDAP

Verzögert Nasdaq Andere Börsenplätze 16:06:48 29.04.2024			% 5 Tage	% 1. Jan.
7,16 ^USD	-1,65 %		-0,14 %	+35,23 %

26.04.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Freitagshandel höher und beenden die Woche mit einem Plus von 3,4%	MT
25.04.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Donnerstagshandel leicht höher	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26.04.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	25.04.
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting	23.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04.04.
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	01.04.
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27.03.
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results	27.03.
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27.03.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	26.03.
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024	13.03.
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024	13.03.
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	06.03.
EDAP TMS S A : Focal One HIFU has potential to address large market impacting thousands of women each year - Form 6-K	04.03.
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis	04.03.
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis	04.03.
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	01.03.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	29.02.
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen EDAP TMS S.A.

Aktien

908548

US2683111072

EDAP

Andere Sprachen

Filter